Can acyclovir stop working over time?
Yes. Acyclovir’s effectiveness can decline with prolonged or repeated use, mainly because viruses can develop resistance to it. In that case, the drug may still reach the infection site, but it may not stop viral replication as effectively as it did earlier. Resistance is uncommon in people with healthy immune systems but is more likely in people with weakened immunity or those receiving repeated courses for chronic or frequent outbreaks.
How does acyclovir resistance happen?
Acyclovir targets viral DNA replication. Resistance usually occurs when the herpesvirus develops genetic changes that reduce how well acyclovir is activated in infected cells or how well the drug inhibits the viral replication machinery. The more exposure a virus has to the drug over time, the greater the chance that resistant variants can be selected and become dominant.
Who is most at risk of reduced effectiveness?
The risk is higher when:
- A person has an immunocompromising condition or is on immune-suppressing treatment.
- A person has chronic herpes infections or frequent recurrences requiring repeated antiviral courses.
- The infection persists despite adequate treatment (which raises concern for resistance).
Does “tolerance” or “addiction” to acyclovir exist?
Acyclovir is not known to cause tolerance in the way some drugs do. The key reason for decreased effectiveness with prolonged use is antiviral resistance or, in some cases, the infection not being fully responsive for other clinical reasons (for example, incorrect diagnosis, inadequate dosing, or insufficient absorption), rather than the body “adapting” to the medication.
What happens if herpes symptoms don’t improve on acyclovir?
If symptoms do not improve as expected during treatment, clinicians typically reassess:
- Whether the diagnosis is correct (the rash might be from a different cause).
- Whether dosing and adherence were adequate.
- Whether kidney function or drug absorption issues could be affecting drug levels.
- Whether resistant herpes is possible, especially in immunocompromised patients.
In resistant cases, healthcare providers may switch to an alternative antiviral option (commonly foscarnet or cidofovir in some settings), based on clinical judgment.
When should someone contact a clinician?
Contact a clinician promptly if:
- Lesions are not improving after several days of acyclovir (or worsen).
- Symptoms recur quickly or become more severe despite treatment.
- The person is immunocompromised and has ongoing or frequent outbreaks.
What can reduce the chance of reduced effectiveness?
Using the medication exactly as prescribed and not stopping early helps ensure viral suppression during each course. If outbreaks become frequent or infections persist, a clinician can evaluate resistance risk and consider longer-term strategies or alternate antivirals when appropriate.
Sources
No sources were provided with the prompt, so I cannot cite evidence here. If you share the material you’re working from (articles, guidelines, or excerpts), I can extract and cite the specific claims from it.